THC Biomed INTL (TFHD) Financial Statements
THC Biomed INTL Financial Overview
THC Biomed INTL's market cap is currently $2.10M. The company's EPS TTM is $-0.02; its P/E ratio is -1.07; THC Biomed INTL has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Oct 22 | Oct 21 | Oct 20 | Jul 19 | Jul 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.45M | $ 3.77M | $ 4.18M | $ 1.49M | $ 925.34K |
| Gross Profit | $ -1.03M | $ -3.17M | $ 3.24M | $ 1.50M | $ 467.22K |
| Operating Income | $ -2.71M | $ -5.94M | $ 205.26K | $ -4.74M | $ -2.41M |
| EBITDA | $ -1.64M | $ -4.96M | $ 1.21M | $ -12.00M | $ -2.41M |
| Net Income | $ -3.07M | $ -6.36M | $ -161.59K | $ -12.70M | $ -12.46M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 484.08K | $ 111.16K | $ 751.46K | $ 991.15K | $ 2.01M |
| Total Assets | $ 14.75M | $ 17.40M | $ 21.77M | $ 18.06M | $ 14.48M |
| Total Debt | $ 1.95M | $ 3.09M | $ 2.79M | $ 3.49M | $ 1.62M |
| Net Debt | $ 1.47M | $ 2.98M | $ 2.04M | $ 2.49M | $ -392.31K |
| Total Liabilities | $ 7.81M | $ 7.61M | $ 6.90M | $ 4.60M | $ 2.27M |
| Stockholders' Equity | $ 6.93M | $ 9.78M | $ 14.87M | $ 13.45M | $ 12.21M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.02M | $ -1.40M | $ -1.31M | $ -9.02M | $ -7.56M |
| Operating Cash Flow | $ -1.86M | $ -1.03M | $ 114.93K | $ -1.87M | $ -2.43M |
| Investing Cash Flow | $ 2.48M | $ -396.92K | $ -1.51M | $ -7.15M | $ -5.06M |
| Financing Cash Flow | $ -250.28K | $ 790.74K | $ 1.16M | $ 8.00M | $ 9.48M |
Currency in CAD
